Dynamic Technology Lab Private LTD Aurinia Pharmaceuticals Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.93 - $9.31 $85,998 - $162,403	17,444 New	17,444 $87,000
Q2 2022 Aug 12, 2022	BUY	$8.95 - $12.8 $416,013 - $594,969	46,482 New	46,482 $467,000
Q1 2021 May 14, 2021	SELL	$12.3 - $18.73 $240,354 - $366,002	-19,541 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$12.94 - $16.05 $252,860 - $313,633	19,541 New	19,541 $270,000
Q2 2019 Aug 14, 2019	SELL	$6.05 - $6.75 $92,437 - $103,133	-15,279 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$6.06 - $7.64 $92,590 - $116,731	15,279 New	15,279 $99,000
Q1 2018 May 14, 2018	SELL	$4.85 - $5.99 $102,301 - $126,347	-21,093 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$4.53 - $7.09 $95,551 - $149,549	21,093	21,093 $96,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.